These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 12438271

  • 1. Systemic gene therapy in human xenograft tumor models by liposomal delivery of the E1A gene.
    Ueno NT, Bartholomeusz C, Xia W, Anklesaria P, Bruckheimer EM, Mebel E, Paul R, Li S, Yo GH, Huang L, Hung MC.
    Cancer Res; 2002 Nov 15; 62(22):6712-6. PubMed ID: 12438271
    [Abstract] [Full Text] [Related]

  • 2. Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer.
    Liao Y, Zou YY, Xia WY, Hung MC.
    Cancer Gene Ther; 2004 Sep 15; 11(9):594-602. PubMed ID: 15272313
    [Abstract] [Full Text] [Related]

  • 3. Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A.
    Ueno NT, Yu D, Hung MC.
    Oncogene; 1997 Aug 18; 15(8):953-60. PubMed ID: 9285690
    [Abstract] [Full Text] [Related]

  • 4. Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer.
    Yoo GH, Hung MC, Lopez-Berestein G, LaFollette S, Ensley JF, Carey M, Batson E, Reynolds TC, Murray JL.
    Clin Cancer Res; 2001 May 18; 7(5):1237-45. PubMed ID: 11350889
    [Abstract] [Full Text] [Related]

  • 5. E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway.
    Ueno NT, Bartholomeusz C, Herrmann JL, Estrov Z, Shao R, Andreeff M, Price J, Paul RW, Anklesaria P, Yu D, Hung MC.
    Clin Cancer Res; 2000 Jan 18; 6(1):250-9. PubMed ID: 10656456
    [Abstract] [Full Text] [Related]

  • 6. The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.
    Chang JY, Xia W, Shao R, Sorgi F, Hortobagyi GN, Huang L, Hung MC.
    Oncogene; 1997 Feb 06; 14(5):561-8. PubMed ID: 9053854
    [Abstract] [Full Text] [Related]

  • 7. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
    Nielsen LL, Lipari P, Dell J, Gurnani M, Hajian G.
    Clin Cancer Res; 1998 Apr 06; 4(4):835-46. PubMed ID: 9563876
    [Abstract] [Full Text] [Related]

  • 8. E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo.
    Cook JL, Miura TA, Iklé DN, Lewis AM, Routes JM.
    Cancer Res; 2003 Jun 15; 63(12):3435-43. PubMed ID: 12810682
    [Abstract] [Full Text] [Related]

  • 9. Technology evaluation: tgDCC-E1A, targeted genetics/MD Anderson.
    Wagner JA.
    Curr Opin Mol Ther; 1999 Apr 15; 1(2):266-70. PubMed ID: 11715950
    [Abstract] [Full Text] [Related]

  • 10. A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.
    Matsubara S, Wada Y, Gardner TA, Egawa M, Park MS, Hsieh CL, Zhau HE, Kao C, Kamidono S, Gillenwater JY, Chung LW.
    Cancer Res; 2001 Aug 15; 61(16):6012-9. PubMed ID: 11507044
    [Abstract] [Full Text] [Related]

  • 11. [Effect of E1A gene on in vitro growth inhibition and radiochemosensitivity of lymph node metastasis cells of human head and neck squamous cell carcinoma].
    Wang XL, Qian XL, Zhao QZ, Xu ZG, Tang PZ.
    Ai Zheng; 2003 Nov 15; 22(11):1140-6. PubMed ID: 14613640
    [Abstract] [Full Text] [Related]

  • 12. In vivo efficacy of folate-targeted lipid-protamine-DNA (LPD-PEG-Folate) complexes in an immunocompetent syngeneic model for breast adenocarcinoma.
    Bruckheimer E, Harvie P, Orthel J, Dutzar B, Furstoss K, Mebel E, Anklesaria P, Paul R.
    Cancer Gene Ther; 2004 Feb 15; 11(2):128-34. PubMed ID: 14671672
    [Abstract] [Full Text] [Related]

  • 13. Systemic tumor suppression by the proapoptotic gene bik.
    Zou Y, Peng H, Zhou B, Wen Y, Wang SC, Tsai EM, Hung MC.
    Cancer Res; 2002 Jan 01; 62(1):8-12. PubMed ID: 11782349
    [Abstract] [Full Text] [Related]

  • 14. Adenovirus-E1A gene therapy enhances the in vivo sensitivity of Ewing's sarcoma to VP-16.
    Zhou RR, Jia SF, Zhou Z, Wang Y, Bucana CD, Kleinerman ES.
    Cancer Gene Ther; 2002 May 01; 9(5):407-13. PubMed ID: 11961663
    [Abstract] [Full Text] [Related]

  • 15. Bcl-2 antisense oligonucleotide overcomes resistance to E1A gene therapy in a low HER2-expressing ovarian cancer xenograft model.
    Bartholomeusz C, Itamochi H, Yuan LX, Esteva FJ, Wood CG, Terakawa N, Hung MC, Ueno NT.
    Cancer Res; 2005 Sep 15; 65(18):8406-13. PubMed ID: 16166319
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of intratracheal lung cancer development by systemic delivery of E1A.
    Chang JY, Xia W, Shao R, Hung MC.
    Oncogene; 1996 Oct 03; 13(7):1405-12. PubMed ID: 8875978
    [Abstract] [Full Text] [Related]

  • 17. Enhanced therapeutic effects of doxorubicin and paclitaxel in combination with liposome-entrapped ends-modified raf antisense oligonucleotide against human prostate, lung and breast tumor models.
    Mewani RR, Tang W, Rahman A, Dritschilo A, Ahmad I, Kasid UN, Gokhale PC.
    Int J Oncol; 2004 May 03; 24(5):1181-8. PubMed ID: 15067340
    [Abstract] [Full Text] [Related]

  • 18. Oncolytic effects of adenovirus mutant capable of replicating in hypoxic and normoxic regions of solid tumor.
    Cho WK, Seong YR, Lee YH, Kim MJ, Hwang KS, Yoo J, Choi S, Jung CR, Im DS.
    Mol Ther; 2004 Nov 03; 10(5):938-49. PubMed ID: 15509511
    [Abstract] [Full Text] [Related]

  • 19. Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway.
    Bao JJ, Le XF, Wang RY, Yuan J, Wang L, Atkinson EN, LaPushin R, Andreeff M, Fang B, Yu Y, Bast RC.
    Cancer Res; 2002 Dec 15; 62(24):7264-72. PubMed ID: 12499268
    [Abstract] [Full Text] [Related]

  • 20. Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu.
    Yu D, Matin A, Xia W, Sorgi F, Huang L, Hung MC.
    Oncogene; 1995 Oct 05; 11(7):1383-8. PubMed ID: 7478560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.